Biodesix Inc CEO Scott Hutton Sells 64,390 Shares [Yahoo! Finance]
Biodesix, Inc. (BDSX)
Company Research
Source: Yahoo! Finance
recent SEC Filing . The transaction was executed with the shares priced at $1.8 each, resulting in a total sale amount of $115,902. Warning! GuruFocus has detected 6 Warning Signs with BDSX. Biodesix Inc is a data-driven diagnostic solutions company with a focus on lung disease. The company leverages its proprietary diagnostic platform to develop testing solutions that assist physicians in diagnosing and treating lung diseases. Biodesix's goal is to provide patients with information that can guide treatment decisions and improve patient outcomes. Over the past year, the insider has sold a total of 95,719 shares and has not made any share purchases. This latest transaction continues a pattern of insider sales for the company. The insider transaction history for Biodesix Inc shows a trend of more insider sales than purchases over the past year, with 6 insider buys and 20 insider sells recorded. On the valuation front, Biodesix Inc's shares were trading at $1.8 on the day of th
Show less
Read more
Impact Snapshot
Event Time:
BDSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDSX alerts
High impacting Biodesix, Inc. news events
Weekly update
A roundup of the hottest topics
BDSX
News
- Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]Yahoo! Finance
- Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024Business Wire
- The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX) [Yahoo! Finance]Yahoo! Finance
- Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingBusiness Wire
BDSX
Earnings
- 3/1/24 - In-Line
BDSX
Analyst Actions
- 3/4/24 - Canaccord Genuity
BDSX
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- BDSX's page on the SEC website